Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON28128
NL-OMON28128
Completed
Not Applicable

Administration of Topical Ophthalmic Medication (ATOM): Feasibility of the spraynozzle technique.

Medspray XMEMS BVColosseum 237521 PV Enschedethe Netherlands053 711 28 35info@medspray.nl0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOphthalmic drug dispersal.

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ophthalmic drug dispersal.
Sponsor
Medspray XMEMS BVColosseum 237521 PV Enschedethe Netherlands053 711 28 35info@medspray.nl
Enrollment
20
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

van Rooij J, Wubbels RJ, de Kruijf WP. A New Spray Device to Deliver Topical Ocular Medication: Penetration of Fluorescein to the Anterior Segment. J Ocul Pharmacol Ther. 2015; 31(9): 531-535. PMID: 26062091

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medspray XMEMS BVColosseum 237521 PV Enschedethe Netherlands053 711 28 35info@medspray.nl

Eligibility Criteria

Inclusion Criteria

  • •1\. Informed consent;
  • •2\. Age \> 18 years.

Exclusion Criteria

  • •1\. Allergy/hypersensitivity for fluorescein;
  • •2\. Previous ocular surgery, including refractive laser surgery;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Administration of Topical Ophthalmic Medication (ATOM): Feasibility of the spraynozzle technique.n.v.t. onderzoek wordt verricht op gezonde vrijwilligersn.v.t.
NL-OMON37543Medspray XMEMS BV20
Not yet recruiting
Phase 2
application of guduchi ghrita as eye drop in an allergic eye disease named vernal keratoconjunctivitis.
CTRI/2023/01/049304Department of Shalakya Tantra
Recruiting
Phase 2
A topical eye drop versus intra-meibomian gland injection of bevacizumab for meibomian gland dysfunction patients.MGD patients with lid margin telangiectasiameibomian gland dysfunction (MGD)&#44lid margin telangiectasia&#44bevacizumab&#44vascularendothelial growth factor (VEGF)&#44lid hygiene
TCTR20201102001Ratchadapiseksompotch Fund30
Completed
Not Applicable
Comparison of the Effects on Promoting Corneal Epithelial Wound Healing Between Human Auto-Serum and Cord Blood SerumEye Injuries
NCT00598299National Taiwan University Hospital100
Unknown
Phase 2
Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular EdemaDiabetic Macular Edema
NCT01523314King Saud University40